Ispire Technology Inc.'s Blockchain-Based Age-Gating System Accepted for FDA Review, Paving Way for Global Scaling
Reuters
Jun 16
Ispire Technology Inc.'s Blockchain-Based Age-Gating System Accepted for FDA Review, Paving Way for Global Scaling
Ispire Technology Inc., a global leader in vaporization technology, has announced that its joint venture, IKE Tech LLC, is undergoing FDA review for its groundbreaking blockchain-based point of use age-gating and Smart-Tag authentication technologies. These innovations, which have demonstrated 100% effectiveness in preventing underage access during clinical trials, are being evaluated as the first standalone age-gating system for Electronic Nicotine Delivery Systems (ENDS). This regulatory review marks a significant step towards global scaling of Ispire's technology, which focuses on consumer safety and harm reduction.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ispire Technology Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN09657) on June 16, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.